Company No:
Contents
| Note | 2026 | 2025 | ||
| £ | £ | |||
| Current assets | ||||
| Stocks | 4 |
|
|
|
| Debtors | 5 |
|
|
|
| Cash at bank and in hand | 6 |
|
|
|
| 139,536 | 718,442 | |||
| Creditors: amounts falling due within one year | 7 | (
|
(
|
|
| Net current assets | 133,266 | 539,533 | ||
| Total assets less current liabilities | 133,266 | 539,533 | ||
| Net assets |
|
|
||
| Capital and reserves | ||||
| Called-up share capital | 8 |
|
|
|
| Profit and loss account |
|
|
||
| Total shareholders' funds |
|
|
Directors' responsibilities:
The financial statements of Abbotplace Limited (registered number:
|
Mr J Larkey
Director |
The principal accounting policies are summarised below. They have all been applied consistently throughout the financial period and to the preceding financial year, unless otherwise stated.
Abbotplace Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Office 102 120 New Cavendish Street, London, W1W 6XX, United Kingdom.
The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.
The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.
In 2026 the directors made the decision that the Company would cease trading. As a result the financial statements have been prepared on a basis other than the going concern basis of preparation. The directors have included in the financial statements any provision for future costs of terminating the business, which were committed to at the balance sheet date and where appropriate the Company's assets have been written down to their net realisable value.
At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.
| 2026 | 2025 | ||
| Number | Number | ||
| Monthly average number of persons employed by the Company during the period, including directors |
|
|
| 2026 | 2025 | ||
| £ | £ | ||
| Amounts recognised as distributions to equity holders in the financial period: | |||
| Interim dividend for the financial period ended 18 January 2026 of £200,000.00 (2025: £115,000.00) per ordinary share | 400,000 | 230,000 | |
| 2026 | 2025 | ||
| £ | £ | ||
| Stocks |
|
|
| 2026 | 2025 | ||
| £ | £ | ||
| Prepayments |
|
|
| 2026 | 2025 | ||
| £ | £ | ||
| Cash at bank and in hand |
|
|
| 2026 | 2025 | ||
| £ | £ | ||
| Accruals |
|
|
|
| Taxation and social security |
|
|
|
|
|
|
| 2026 | 2025 | ||
| £ | £ | ||
| Allotted, called-up and fully-paid | |||
|
|
|
|